NO20023425L - Fremgangsmåte for lindring av angst - Google Patents

Fremgangsmåte for lindring av angst

Info

Publication number
NO20023425L
NO20023425L NO20023425A NO20023425A NO20023425L NO 20023425 L NO20023425 L NO 20023425L NO 20023425 A NO20023425 A NO 20023425A NO 20023425 A NO20023425 A NO 20023425A NO 20023425 L NO20023425 L NO 20023425L
Authority
NO
Norway
Prior art keywords
procedures
relieving anxiety
anxiety
relieving
Prior art date
Application number
NO20023425A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023425D0 (no
Inventor
Robert F Mayol
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27047894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023425(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20023425D0 publication Critical patent/NO20023425D0/no
Publication of NO20023425L publication Critical patent/NO20023425L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20023425A 2000-01-18 2002-07-17 Fremgangsmåte for lindring av angst NO20023425L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48416100A 2000-01-18 2000-01-18
US09/588,221 US6150365A (en) 1999-08-05 2000-06-06 Anxiety method
PCT/US2000/028800 WO2001052853A1 (en) 2000-01-18 2000-10-18 Anxiety method

Publications (2)

Publication Number Publication Date
NO20023425D0 NO20023425D0 (no) 2002-07-17
NO20023425L true NO20023425L (no) 2002-09-05

Family

ID=27047894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023425A NO20023425L (no) 2000-01-18 2002-07-17 Fremgangsmåte for lindring av angst

Country Status (22)

Country Link
US (1) US6150365A (de)
EP (1) EP1248622B1 (de)
JP (1) JP2003520236A (de)
KR (1) KR20020073176A (de)
CN (1) CN1424911A (de)
AR (1) AR028201A1 (de)
AT (1) ATE300302T1 (de)
AU (1) AU775591B2 (de)
BR (1) BR0016971A (de)
CA (1) CA2406732A1 (de)
CZ (1) CZ20022461A3 (de)
DE (1) DE60021609D1 (de)
HU (1) HUP0204285A3 (de)
IL (1) IL150019A0 (de)
MX (1) MXPA02007003A (de)
NO (1) NO20023425L (de)
NZ (1) NZ520823A (de)
PL (1) PL355966A1 (de)
RU (1) RU2254132C2 (de)
TW (1) TWI226831B (de)
UY (1) UY26440A1 (de)
WO (1) WO2001052853A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069251A1 (en) * 1999-08-05 2003-04-10 Yevich Joseph P. Antianxiety composition
US20050137206A1 (en) * 1999-08-05 2005-06-23 Yevich Joseph P. Method for treatment of anxiety and depression
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method
WO2002077168A2 (en) * 2001-03-22 2002-10-03 Merck & Co., Inc. Mch1r deficient mice
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
WO2003009851A1 (en) * 2001-07-24 2003-02-06 Bristol-Myers Squibb Company R-6-hydroxy-buspirone
WO2003010161A1 (en) * 2001-07-24 2003-02-06 Bristol-Myers Squibb Company S-6-hydroxy-buspirone
US6897309B2 (en) * 2002-08-12 2005-05-24 Bristol-Myers Squibb Company Process for hydroxyazapirones
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
US20040213842A1 (en) * 2003-01-30 2004-10-28 Dynogen Pharmaceuticals, Inc. Methods of treating gastrointestinal tract disorders using sodium channel modulators
CN101273046B (zh) * 2005-09-28 2011-05-25 弗·哈夫曼-拉罗切有限公司 作为加压素受体拮抗剂的吲哚-3-基-羰基氮杂螺环衍生物
RU2611376C2 (ru) 2010-10-15 2017-02-21 Контера Фарма Апс Фармацевтическая композиция для лечения, профилактики или облегчения двигательных расстройств и ее применение
NZ700474A (en) 2012-04-18 2016-10-28 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
PT3160464T (pt) * 2014-06-26 2018-10-12 Contera Pharma Aps 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4409223A (en) * 1982-08-06 1983-10-11 Riblet Leslie A Anxiolytic method
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
WO1998024411A2 (en) * 1996-12-04 1998-06-11 Bristol-Myers Squibb Company Method for oral administration of buspirone
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method

Also Published As

Publication number Publication date
ATE300302T1 (de) 2005-08-15
NO20023425D0 (no) 2002-07-17
RU2002118304A (ru) 2004-01-10
AU1213001A (en) 2001-07-31
DE60021609D1 (de) 2005-09-01
CA2406732A1 (en) 2001-07-26
EP1248622A1 (de) 2002-10-16
NZ520823A (en) 2004-05-28
BR0016971A (pt) 2002-10-15
CZ20022461A3 (cs) 2003-09-17
CN1424911A (zh) 2003-06-18
TWI226831B (en) 2005-01-21
JP2003520236A (ja) 2003-07-02
US6150365A (en) 2000-11-21
EP1248622B1 (de) 2005-07-27
EP1248622A4 (de) 2004-02-04
HUP0204285A3 (en) 2004-07-28
RU2254132C2 (ru) 2005-06-20
WO2001052853A1 (en) 2001-07-26
UY26440A1 (es) 2001-08-27
AR028201A1 (es) 2003-04-30
AU775591B2 (en) 2004-08-05
PL355966A1 (en) 2004-05-31
KR20020073176A (ko) 2002-09-19
MXPA02007003A (es) 2003-01-28
IL150019A0 (en) 2002-12-01
HUP0204285A2 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
DE60135078D1 (de) Hochfrequenzvorrichtung
DE60123990D1 (de) Medizinische greifvorrichtung
NO20025580L (no) Medisinsk anordning
DE60105874D1 (de) Ophthalmisches Gerät
DE60123496D1 (de) Verbindungsherstellungsvorrichtung
DE50013364D1 (de) Filtervorrichtung
NO20023425L (no) Fremgangsmåte for lindring av angst
DE60120082D1 (de) Spinnvorrichtung
DE60122836D1 (de) Ophthalmische Linse-Erzeugungsvorrichtung
DE60127017D1 (de) Aufschlämmungsrückfluss-Vorrichtung
DE60109663D1 (de) Ophthalmische Einrichtung
NO20005524L (no) Ror-i-roranordning
DE60142401D1 (de) Verbindungsverfahren
DE10194843T1 (de) Anschlusseinrichtung
NO20032156D0 (no) Behandling av angstforstyrrelser
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
ATE250611T1 (de) Pyranoindole zur glaukombehandlung
DE60119061D1 (de) Justierbare Begrenzungsvorrichtung
DE50100757D1 (de) Filtervorrichtung
NO20031092L (no) Fremgangsmåte for fjerning av urenheter
DE60125959D1 (de) Unterscheidung zwischen gnrh-i und gnrh-ii
ATA16952001A (de) Filtereinrichtung
EP1283262A4 (de) Die expression des neurotrophen faktors induzierende agenz
DE50108156D1 (de) Filtereinrichtung
NO20002993D0 (no) FremgangsmÕte for bonuspoenganvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application